Clinical Trial Update: Effective Pain Management During Shoulder Replacement Surgery With EXPAREL [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating EXPAREL for postoperative pain management in shoulder replacement has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain Postoperative
• Shoulder Osteoarthritis

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: TriHealth Inc. | Conditions: Pain, Postoperative, Shoulder Osteoarthritis | Phase 4 | Status: WITHDRAWN